GlaxoSmithKline Pharma Share Price

₹ 2,575.00

+₹43.60 (1.72%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: GLAXO
|
Pharmaceuticals

GlaxoSmithKline Pharma Share Price Today

As of 3 Nov 2026, GlaxoSmithKline Pharma share price is ₹2,575.00. The stock opened at ₹2,540.40, compared to its previous close of ₹2,531.40. During today's trading session, GlaxoSmithKline Pharma share price moved in the range of ₹2,540.40 to ₹2,605.90, with an average price of ₹2,573.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,088.10 and a high of ₹3,120.70.

Share price over the last 1 day rose from 2562.30 to 2575.00, ranging between 2546.00 and 2605.90.
₹2,540.40
1.72% up today
₹2,605.90
1D LOW
1D HIGH

GlaxoSmithKline Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 11.60% YoY
Latest Earning
Net Profit TrendUp by 11.69% YoY
Latest Earning
Revenue TrendUp by 1.85% YoY
Stock Performance
OutperformingBeat Nifty by 0.4 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 17.91%
Shareholding Pattern
FIIFII decreased stake by 0.80%
GlaxoSmithKline Pharma stock performance
Open₹2,540.40
High₹2,605.90
Low₹2,540.40
Prev. close₹2,531.40
GlaxoSmithKline Pharma trading activity
Volume66,520
Average traded price₹2,577.74
Last traded time03:29:54 03 Nov
Last traded quantity20
Circuit
L
H
₹2,025.20
₹3,037.60
52-week
L
H
₹2,088.10
₹3,120.70
Mkt Cap Cr
42,072.84
P/E
40.1
P/B
18.89
ROA
24.7%
ROE
45.69%
ROCE
61.23%
Quick Ratio
1.77
EV/EBITDA
26.91

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Glaxosmi. Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Glaxosmi. Pharma appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Glaxosmi. Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GlaxoSmithKline Pharma Company Background

ISIN
INE159A01016
Sector Market Cap
₹ 42,072.84 Cr

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

GlaxoSmithKline Pharma Financial Highlights

  • Revenue: GlaxoSmithKline Pharma reported revenue of ₹3,967.03 crore in FY26 vs ₹3,895.14 crore in FY25. It showed an increase of 1.85% on a yearly basis.
  • Operating Profit: GlaxoSmithKline Pharma reported an operating profit of ₹1,406.01 crore in FY26 vs ₹1,259.88 crore in FY25. It showed an increase of 11.60% on a year-on-year basis.
  • Net Profit: GlaxoSmithKline Pharma reported a net profit of ₹1,035.98 crore in FY26 vs ₹927.58 crore in FY25. It showed an increase of 11.69% on a yearly basis.

GlaxoSmithKline Pharma Quarterly Result Highlights

  • GlaxoSmithKline Pharma reported revenue of ₹982.20 crore in Jun 2026, compared with ₹1,031.25 crore in Mar 2026, representing a decrease of 4.76% on a quarter-on-quarter (QoQ) basis.
  • GlaxoSmithKline Pharma reported an operating profit of ₹322.45 crore in Jun 2026, compared with ₹373.10 crore in Mar 2026, representing a decrease of 13.58% on a quarter-on-quarter (QoQ) basis.
  • GlaxoSmithKline Pharma reported a profit of ₹237.18 crore in Jun 2026, compared with ₹277.86 crore in Mar 2026, reflecting a decrease of 14.64% on a QoQ basis.
  • The earnings per share (EPS) of GlaxoSmithKline Pharma stood at ₹61.15 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
75.00%
FII
4.75%
Other DII
2.41%
Retail and other
11.77%
Mutual funds
6.07%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20254.64%
Mar 20264.62%
Jun 20264.79%
Sep 20264.75%

GlaxoSmithKline Pharma Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

GlaxoSmithKline Pharma Share Price History

GlaxoSmithKline Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹2,494.30 / ₹2,531.40
+1.49%
30 Oct 26
₹2,527.60 / ₹2,494.30
-0.83%
29 Oct 26
₹2,498.00 / ₹2,515.10
+0.68%
28 Oct 26
₹2,469.90 / ₹2,498.00
+1.04%
Show more

GlaxoSmithKline Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,821.67₹3,749.21₹3,453.71₹3,251.72
Other Income₹145.36₹145.93₹122.59₹100.66
Total Revenue₹3,967.03₹3,895.14₹3,576.30₹3,352.38
Total Expenses₹2,581.65₹2,639.95₹2,616.50₹2,515.02
Profit Before Tax₹1,406.01₹1,259.88₹816.19₹836.40
Tax₹370.03₹332.30₹226.23₹228.76
Profit After Tax₹1,035.98₹927.58₹589.96₹607.64
EPS - Basic₹61.15₹54.76₹34.83₹36.05
EPS - Diluted₹61.15₹54.76₹34.83₹36.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,385.39₹1,255.19₹959.80₹841.49
Income before WC changes₹1,320.14₹1,186.78₹914.67₹801.49
Change in Assets₹55.14₹29.53-₹107.15₹51.14
Change in Liabilities-₹153.31₹155.30₹168.17-₹96.89
Change in WC-₹98.17₹184.83₹61.02-₹45.75
Cash flow from Operations₹903.30₹1,289.90₹582.02₹484.23
Cash flow from Investing₹396.98-₹45.80₹8.71₹807.85
Cash flow from Financing-₹737.08-₹769.42-₹561.50-₹1,543.32
Total Cash Flow₹563.20₹474.68₹29.23-₹251.25
Cash (Start of the year)₹538.85₹64.17₹34.94₹286.19
Cash (End of the year)₹1,102.05₹538.85₹64.17₹34.94

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹717.67₹698.18₹758.20₹832.32
Current Assets₹3,606.20₹3,409.88₹2,798.42₹2,494.26
Total Assets₹4,323.87₹4,108.07₹3,556.62₹3,326.58
Current Liabilities₹1,779.10₹1,905.15₹1,524.95₹1,326.37
Net Current Asset₹1,827.09₹1,504.73₹1,273.47₹1,167.89
Non-Current Liabilities₹277.35₹251.60₹254.03₹258.94
Equity Capital₹2,267.42₹1,951.31₹1,777.64₹1,741.27
Total Equity & Liabilities₹4,323.87₹4,108.07₹3,556.62₹3,326.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,790.20₹3,723.49₹3,407.25₹3,216.34
Other Income₹142.56₹142.56₹123.48₹101.51
Total Revenue₹3,932.76₹3,866.05₹3,530.73₹3,317.86
Total Expenses₹2,559.17₹2,622.31₹2,578.08₹2,484.50
Profit Before Tax₹1,376.23₹1,248.44₹809.04₹832.39
Tax₹364.40₹329.39₹224.35₹227.69
Profit After Tax₹1,011.82₹919.05₹584.69₹604.71
EPS - Basic₹59.59₹54.01₹34.51₹35.88
EPS - Diluted₹59.73₹54.24₹34.51₹35.88

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,373.59₹1,243.74₹952.65₹837.49
Income before WC changes₹1,308.77₹1,174.77₹906.51₹796.63
Change in Assets₹62.42₹22.37-₹100.82₹42.28
Change in Liabilities-₹169.67₹163.81₹165.37-₹81.30
Change in WC-₹107.25₹186.18₹64.55-₹39.02
Cash flow from Operations₹881.42₹1,280.03₹578.94₹487.94
Cash flow from Investing₹385.25-₹36.53₹14.97₹805.19
Cash flow from Financing-₹737.07-₹769.42-₹561.50-₹1,544.18
Total Cash Flow₹529.60₹474.07₹32.41-₹251.05
Cash (Start of the year)₹536.22₹62.15₹29.74₹280.79
Cash (End of the year)₹1,065.82₹536.22₹62.15₹29.74

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹731.79₹717.38₹781.96₹860.98
Current Assets₹3,543.12₹3,383.55₹2,765.84₹2,466.72
Total Assets₹4,274.91₹4,100.93₹3,547.80₹3,327.70
Current Liabilities₹1,757.11₹1,900.81₹1,510.94₹1,317.03
Net Current Asset₹1,786.01₹1,482.73₹1,254.90₹1,149.69
Non-Current Liabilities₹276.63₹250.89₹252.76₹257.67
Equity Capital₹2,241.17₹1,949.23₹1,784.09₹1,753.00
Total Equity & Liabilities₹4,274.91₹4,100.93₹3,547.80₹3,327.70
* All values are in INR Crore
GlaxoSmithKline Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
492575.100
0000
0000
0000
0000
Total bid quantity49
Total ask quantity0
GlaxoSmithKline Pharma technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
43.69
Neutral
ATR (14)
63.7
Neutral
STOCH(9,6)
78.37
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
29.95
Bearish
UO(9)
54.17
Neutral
ROC(12)
-0.3
Bearish
WillR(14)
-21.63
Neutral
Period
Simple value
Exponential vaue
5D
2502.24
2503.41
10D
2475.53
2504.04
20D
2532.47
2551.94
50D
2755.72
2635.87
100D
2617.76
2623.9
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

GlaxoSmithKline Pharma
Pharmaceuticals
Add Stock
Add Another

GlaxoSmithKline Pharma Returns Calculator

Ex-date: 29 May 2026

GlaxoSmithKline Pharma Latest News

1 month ago
Tata Teleservices, GSK Pharma, MRPL shares surge amid spike in volumes; check full list
5 months ago
Bajaj Auto, Bank of India, GSK Pharma, UNO Minda dividend record date on May 29: Last day to buy for payout
Showing news item 1 of 2

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

GlaxoSmithKline Pharma Share Price FAQs

Please be aware that GlaxoSmithKline Pharma stock prices are subject to continuous fluctuations due to various factors.